Loss of the C terminus of melanocortin receptor 2 (MC2R) results in impaired cell surface expression and ACTH insensitivity.
OBJECTIVE
Mutations in melanocortin receptor 2 (MC2R) and its related melanocortin receptor accessory protein (MRAP) cause familial glucocorticoid deficiency. We identified a novel MC2R mutation, K289fs. This unique mutation in the C terminus of MC2R is located in the intracellular part of the protein for which the exact function is unknown.


METHODS
A 6-wk-old boy presented with severe hypoglycemia, unmeasurable cortisol, and grossly elevated ACTH but normal electrolytes. Genetic analysis revealed homozygote K289fs mutation in MC2R. His parents and siblings were heterozygous but phenotypically normal.


RESULTS
The role of the C terminus of MC2R was studied in two cell systems. Because the K289fs mutant changes the last eight amino acids of the protein and leads to protein elongation, wild-type MC2R and C-terminally mutated constructs were tested for activity to respond to ACTH in an OS3 cell-based reporter assay. Wild-type and alanine-substituted constructs responded normally to ACTH. By contrast K289fs and M290X had a total loss of activity. Cell surface assays and confocal localization studies revealed that K289fs and M290X receptors were not found at the cell surface, indicating that their transport from the endoplasmic reticulum to the cell membrane is disrupted. Interestingly, coimmunoprecipitation experiments showed no alteration in the interaction of mutant MC2R with MRAP, suggesting that interaction between these two proteins does not guarantee normal localization.


CONCLUSIONS
Loss of the C terminus of MC2R impairs cell surface expression and ACTH sensitivity but does not disrupt interaction of MC2R with MRAP. These findings highlight the extreme sensitivity of MC2R to structural disruption.
Pediatric Endocrinology and Diabetology, University Children's Hospital Bern, Bern, Switzerland.
Andrea
A
Hirsch
Eirini
E
Meimaridou
Monica
M
Fernandez-Cancio
Amit V
AV
Pandey
María
M
Clemente
Laura
L
Audi
Adrian J L
AJ
Clark
Christa E
CE
Flück
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000704:Analysis of Variance; D015153:Blotting, Western; D002462:Cell Membrane / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000172:deficiency*; D057809:HEK293 Cells; D006801:Humans; D047468:Immunoprecipitation; D007223:Infant; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D044103:Receptor, Melanocortin, Type 2 / Q000235:genetics* / Q000378:metabolism
D005938:Glucocorticoids; C458099:MRAP protein, human; D008565:Membrane Proteins; D044103:Receptor, Melanocortin, Type 2; D000324:Adrenocorticotropic Hormone